St. Joseph’s Health and Renalytix partnered to implement an advanced clinical care model designed to improve kidney health in patients with type 2 diabetes and early-stage chronic kidney disease. The Renalytix KidneyIntelX™ platform will be integrated with St. Joseph’s Health care management to help prevent patients with diabetes and early-stage kidney disease from unnecessarily progressing to significant disease and/or kidney failure. KidneyIntelX is designed to enable primary care and specialist physicians to easily understand risk and implement St. Joseph’s Health medication management, nutrition and education intervention protocols on a timely basis.
St. Joseph’s Health is part of Trinity Health, one of the largest multi-institutional Catholic health care delivery systems in the U.S., serving more than 30 million people across 25 states. KidneyIntelX test risk assessment will be available through St. Joseph’s Hospital’s electronic health record (EHR) system, providing access to primary care physicians, endocrinologists, nephrologists, and care teams. Read more.
